期刊
PHARMACEUTICS
卷 14, 期 8, 页码 -出版社
MDPI
DOI: 10.3390/pharmaceutics14081557
关键词
flash nanoprecipitation; conjunctivitis; nanoparticles; zein; hyaluronic acid; ciprofloxacin
资金
- Programa Operacional Regional do Centro within the European Social Fund (ESF) [CENTRO-04-3559-FSE-000162]
- European Union/ERDF [0633_BIOIMPACE_4_A]
- European Regional Development Fund (ERDF) under the Interreg V-A Spain-Portugal (POCTEP)
- ESF
This study utilized flash nanoprecipitation technique to produce zein and hyaluronic acid nanoparticles loaded with ciprofloxacin, and evaluated their potential for ocular drug delivery. The results showed that ZeinCPX_HA NPs had suitable particle size and polydispersity index, and maintained stability through the freeze-drying and resuspension process. Moreover, the nanoparticles exhibited good biocompatibility and sustained release of ciprofloxacin.
Bacterial conjunctivitis is a worldwide problem that, if untreated, can lead to severe complications, such as visual impairment and blindness. Topical administration of ciprofloxacin is one of the most common treatments for this infection; however, topical therapeutic delivery to the eye is quite challenging. To tackle this, nanomedicine presents several advantages compared to conventional ophthalmic dosage forms. Herein, the flash nanoprecipitation technique was applied to produce zein and hyaluronic acid nanoparticles loaded with ciprofloxacin (ZeinCPX_HA NPs). ZeinCPX_HA NPs exhibited a hydrodynamic diameter of <200 nm and polydispersity index of <0.3, suitable for ocular drug delivery. In addition, the freeze-drying of the nanoparticles was achieved by using mannitol as a cryoprotectant, allowing their resuspension in water without modifying the physicochemical properties. Moreover, the biocompatibility of nanoparticles was confirmed by in vitro assays. Furthermore, a high encapsulation efficiency was achieved, and a release profile with an initial burst was followed by a prolonged release of ciprofloxacin up to 24 h. Overall, the obtained results suggest ZeinCPX_HA NPs as an alternative to the common topical dosage forms available on the market to treat conjunctivitis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据